We are live on ! Find out more
CBIO

Crescent Biopharma

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$75.9M
BI
2
BVF Inc
California
$50.5M
FFM
3
Fairmount Funds Management
Pennsylvania
$50.5M
VA
4
VR Adviser
New York
$39.2M
FIS
5
FCPM III Services
Netherlands
$30.8M
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
$27.7M +$16.1M +1,398,318 +1,252%
VPC
7
Vestal Point Capital
New York
$27.6M
OM
8
Opaleye Management
Massachusetts
$24.1M +$1.54M +134,315 +11%
TCM
9
Tang Capital Management
California
$21.3M +$3.3M +287,602 +33%
Vanguard Capital Management
10
Vanguard Capital Management
Pennsylvania
$14.7M +$9.2M +801,395 New
LGM
11
Logos Global Management
California
$8.86M -$1.35M -117,500 -20%
BCM
12
Boxer Capital Management
California
$8.33M
DTC
13
Deep Track Capital
Connecticut
$8.33M
NCM
14
NEXTBio Capital Management
California
$6.85M
RI
15
RTW Investments
New York
$6.85M
RCP
16
Remedium Capital Partners
Florida
$6.64M
Millennium Management
17
Millennium Management
New York
$5.94M +$3M +261,671 +423%
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$5.58M -$397K -34,574 -10%
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$5.51M
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$4.85M
Goldman Sachs
21
Goldman Sachs
New York
$4.2M +$2.33M +203,230 +805%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$3.92M +$1.8M +156,587 +274%
PA
23
Perceptive Advisors
New York
$3.8M -$2.83M -246,744 -54%
Marshall Wace
24
Marshall Wace
United Kingdom
$3.69M +$2.05M +178,954 +820%
EAM
25
Exome Asset Management
New York
$2.81M +$1.76M +153,191 New